Published: Apr 21, 2026
Written by Klarity Editorial Team
Published: Apr 21, 2026

You’ve probably noticed: every third patient is asking about Ozempic, and half your caseload is dealing with weight gain from psych meds. The GLP-1 boom isn’t slowing down—by late 2025, roughly 6% of Americans (20 million people) were actively taking these medications, many paying out-of-pocket because their insurance won’t cover it.
For psychiatrists, this isn’t just a trend to watch—it’s a genuine practice expansion opportunity. You already manage chronic treatments, understand behavior change, and have the prescriptive authority. The question isn’t whether you can add GLP-1 services. It’s whether you can scale them profitably without working yourself into the ground.
Here’s how to build a sustainable weight-loss service line that complements your psychiatric practice instead of consuming it.
You’re Already Halfway There
A late-2023 survey found nearly half of psychiatrists were already prescribing or recommending GLP-1 medications—primarily to address antipsychotic-induced weight gain or co-morbid obesity. Unlike primary care docs scrambling to add obesity medicine to already-packed schedules, you’re dealing with this problem daily.
Your patients on olanzapine, quetiapine, or valproate? They’ve likely gained 20-40 pounds and feel trapped between their mental health and physical health. Offering GLP-1 treatment gives them a way forward that doesn’t require choosing one over the other.
The Mental Health-Weight Loss Connection
Here’s what obesity medicine specialists often miss: weight loss isn’t just about calories and injections. It’s about motivation, emotional eating, body image struggles, and the psychological stamina to stick with lifestyle changes for months. That’s your wheelhouse.
Psychiatrists bring expertise in:
Patients who’ve failed every diet because of unaddressed depression or trauma? They need a provider who gets the mental health piece. That’s a competitive advantage generic telehealth weight-loss mills can’t replicate.
The Numbers Are Staggering
In 2024 alone, GLP-1 use for weight loss increased roughly 600% over the prior six years. By 2025, about 2% of Americans were using these medications specifically for obesity (double that if you count diabetes patients).
With 75% of Americans overweight or obese, and only a handful of board-certified obesity medicine specialists per state, tens of thousands of new patients start GLP-1 treatments every week. Most are going to telehealth platforms or waiting months for appointments because their PCPs don’t have capacity.
Cash-Pay Is the Standard Model
Most insurers still don’t cover GLP-1s for weight loss—only 13 state Medicaid programs covered them as of mid-2024 (California, Pennsylvania, and Illinois among them). Private insurance coverage remains spotty, with most plans excluding obesity drugs entirely or requiring extensive prior authorization proving multiple failed diet attempts.
Translation: patients expect to pay out-of-pocket. They’re already spending $200-500/month on compounded semaglutide or $1,000+ for brand-name Wegovy. A $150-200 monthly consult fee barely registers when the medication itself costs more than rent.
This creates a business opportunity that doesn’t depend on insurance reimbursement headaches—but it also means you’re competing on value, not just credentials.
The biggest mistake psychiatrists make when adding GLP-1 services: treating every patient like a complex psychiatric case requiring 60-minute deep dives.
Initial Consultation Template (30-45 minutes):
Follow-Up Visits (15-20 minutes monthly during dose escalation):
By month 3-4 when patients are stable on maintenance doses, you can extend visits to every 2-3 months with asynchronous weight check-ins between appointments.
You don’t need to do everything yourself. In fact, you shouldn’t.
What to delegate:
What you keep:
Some psychiatrists set up alternating visit structures: they see patients at months 1, 3, and 5, while a nurse practitioner or health coach handles months 2, 4, and 6. As long as you’re supervising appropriately (which varies by state—more on that below), this doubles your capacity without doubling your time.
Essential tools for scale:
Integrated telehealth EHR with video visits, e-prescribing, and secure messaging. Platforms like Klarity handle this infrastructure so you’re not cobbling together Zoom + separate EMR + fax machine for prescriptions.
Automated appointment scheduling that shows your available slots and lets patients book directly—no back-and-forth emails.
Template documentation for common scenarios: initial GLP-1 evaluation, routine titration visit, side effect management, patient education on plateau/maintenance. You can complete a follow-up note in 3 minutes instead of 15.
Remote monitoring where helpful: Some providers issue connected scales or use apps where patients log weekly weights. You review trends at a glance rather than spending visit time collecting data.
Patient education automation: When you e-prescribe semaglutide, an automated message goes out with injection instructions, common side effects, and when to call. FAQ chatbots on your website handle ‘Do I need to refrigerate this?’ questions.
The ROI on good tech is immediate: you see more patients per hour, spend less time on admin work, and patients get faster responses to routine questions.
Let’s be realistic about patient acquisition and revenue:
Typical cash-pay structure:
Patient volume scenarios:
Part-time GLP-1 practice (10 hours/week):
Full-time focus (30 hours/week patient-facing):
This doesn’t include any revenue from therapy/counseling services or medication sales if you operate your own pharmacy (which some practices do, though it adds regulatory complexity).
Here’s where most ‘start a cash-pay practice’ advice falls apart. They’ll tell you psychiatric patients cost ‘$30-50 to acquire through SEO or Google Ads’—which is complete fantasy.
Reality of DIY marketing:
For GLP-1 weight-loss patients specifically, competition is fierce on Google and costs are often higher because you’re competing with well-funded telehealth startups spending millions on ads.
This is where platforms like Klarity Health change the math entirely.
Instead of spending $3,000-5,000/month on marketing with uncertain results, you pay a standard listing fee per new patient lead—only when a qualified patient books with you.
What you get:
The business case: If a platform charges you $150-200 per new patient lead, and that patient stays with you for an average of 6 months of follow-ups generating $750+ in revenue, your ROI is guaranteed. Compare that to gambling $5,000 on Google Ads that might generate leads in 3 months if you’re lucky and know what you’re doing.
For most providers—especially those starting out or scaling—removing patient acquisition risk entirely is worth the per-patient fee. You can always layer in your own marketing later once cash flow is established.
GLP-1 medications are not controlled substances, so you’re not dealing with Ryan Haight Act restrictions. That said, you must be licensed in the patient’s state, and if you’re a PMHNP, state scope-of-practice rules determine whether you can prescribe independently or need physician supervision.
California:
Texas:
Florida:
New York:
Pennsylvania:
Illinois:
Bottom line: If you’re a psychiatrist (MD/DO), you can practice GLP-1 telehealth in any state where you hold a license. PMHNPs need to navigate supervision requirements in most states, but experienced NPs in NY, IL, and (soon) CA can operate independently.
The biggest burnout driver isn’t hard work—it’s uncontrolled work.
Smart boundaries:
Some psychiatrists love the variety of splitting time between mental health and weight management. Others find it cognitively exhausting to constantly switch gears.
Two viable models:
Integrated practice: Mix GLP-1 patients into your regular psychiatric schedule. Advantage: many psych patients are GLP-1 candidates, so you’re already seeing them. Downside: more context-switching.
Dedicated days/times: ‘Tuesdays and Thursdays 1-5pm are weight-loss only.’ Advantage: you’re in ‘GLP-1 mode’ and workflows are more efficient. Downside: less scheduling flexibility for patients.
Neither is wrong—pick what matches your working style.
Telehealth’s blessing and curse: you can work from anywhere, which means work can bleed into everywhere.
Boundaries that prevent this:
Research on physician burnout consistently shows that schedule control and flexible work arrangements significantly reduce burnout rates. Telehealth enables this—but only if you design your practice to take advantage of it.
Jumping into GLP-1 prescribing without proper training is a recipe for imposter syndrome and anxiety.
Worth pursuing:
The upfront investment pays off in reduced stress and better patient outcomes.
GLP-1 therapy typically lasts 12-18+ months, but retention isn’t automatic. Patients drop off when:
Retention strategies:
1. Monthly support groups (group telehealth):
A 30-minute monthly Zoom with 10-15 patients discussing challenges, wins, nutrition tips, etc. This:
2. Educational drip campaigns:
Automated emails or portal messages covering: ‘Week 4: Managing nausea,’ ‘Month 3: What to do when weight loss slows,’ ‘Month 6: Transitioning to maintenance’
3. Celebrate milestones:
When a patient hits 10% body weight loss, acknowledge it. Small gestures (congratulatory message, certificate, feature in your newsletter if they consent) reinforce their progress.
4. Coordinate with other providers:
Partner with dietitians, personal trainers, or therapists who specialize in body image. Offering warm referrals keeps patients in an ecosystem of support.
5. Be transparent about cost:
If medication prices spike due to shortages or insurance changes, communicate early. Help patients explore options (compounded alternatives, patient assistance programs) rather than letting them ghost when they can’t afford it.
The GLP-1 opportunity is real—20 million Americans are actively taking these medications, and demand continues to outpace provider supply. For psychiatrists, this isn’t about abandoning mental health practice to chase a trend. It’s about leveraging your existing expertise in behavior change, medication management, and patient relationships to serve a population desperate for comprehensive care.
Keys to scaling without burning out:
✅ Standardize workflows so routine visits are efficient, not exhausting
✅ Delegate non-specialist tasks to support staff, NPs, or health coaches
✅ Use technology to automate repetitive work (scheduling, documentation, patient education)
✅ Set clear capacity limits and protect your personal time
✅ Partner with platforms (like Klarity) that handle patient acquisition so you’re not gambling thousands on marketing
✅ Stay within your state’s scope-of-practice rules and maintain proper licensure
✅ Invest in your own education and peer support to build confidence
Done right, a GLP-1 service line can add $10,000-30,000+ monthly revenue while actually improving your quality of life—you’re helping patients achieve transformative results, using skills you already have, and building a practice model that’s financially sustainable.
The alternative—ignoring the demand or trying to wing it without systems—leads to overwhelm, poor outcomes, and provider regret.
Ready to explore adding GLP-1 services without the patient acquisition gamble? Platforms like Klarity Health connect psychiatric providers with pre-qualified patients seeking weight-loss treatment via telehealth, handling the marketing and infrastructure so you can focus on delivering great care. It’s the difference between spending months building something from scratch and seeing your first patients next week.
Can psychiatrists legally prescribe GLP-1 medications for weight loss?
Yes. Psychiatrists (MD/DO) hold full prescriptive authority and can prescribe GLP-1 medications in any state where they’re licensed. These drugs are not controlled substances, so standard telehealth prescribing rules apply—no Ryan Haight Act restrictions. The key is practicing within standard of care: obtaining appropriate history, conducting a medical evaluation (via video is fine), and monitoring patients regularly.
Do I need obesity medicine certification to offer GLP-1 treatment?
No, but it helps. Obesity medicine certification (through ABOM) builds credibility and knowledge, but it’s not required to prescribe these medications. Many psychiatrists offer GLP-1 services after completing focused CME on obesity pharmacotherapy, metabolism, and nutrition counseling. Start with what you know (medication management, behavior change, mental health) and layer in obesity-specific education over time.
What if I’m a PMHNP—can I prescribe GLP-1s independently?
It depends on your state. In states with full practice authority for experienced NPs (like New York after 3,600 hours, Illinois after 4,000 hours + education, or California starting 2026), yes. In states requiring physician collaboration (Texas, Pennsylvania, Florida for psych NPs), you’ll need a supervising physician agreement. Check your state’s scope-of-practice rules or join a platform that handles supervision structures for NPs.
How much should I charge for GLP-1 consultations?
Industry standard for cash-pay: $200-300 for initial evaluation (45 min), $100-150 for follow-ups (15-20 min). Some providers offer monthly subscription packages ($400-500/month including consults, coaching access, and medication coordination). Price based on your market, competition, and the value you provide—if you’re offering comprehensive mental health + weight management, you can command premium pricing compared to generic telehealth clinics.
Will insurance cover my GLP-1 consultation visits?
Sometimes. If you bill standard E/M codes for obesity counseling and the patient’s insurance covers preventive services, you might get reimbursed for visits—but the medication often isn’t covered unless the patient has diabetes. Most providers find cash-pay simpler for weight-loss services due to insurance exclusions and prior authorization hassles. Check with your billing department or clearinghouse about coding obesity visits (E/M plus ICD-10 code E66.01 for morbid obesity).
How do I handle patients who plateau or stop losing weight?
This is common around months 4-6. Address it proactively: reassess dietary adherence, increase physical activity, rule out medical causes (thyroid, cortisol), consider dose adjustment if not at max, and provide psychological support (plateaus are normal and don’t mean failure). Some patients benefit from adding metformin or switching GLP-1 medications. Group support sessions help normalize plateaus and keep motivation up. If plateau persists despite optimization, refer to obesity medicine specialist or endocrinologist for advanced options.
What are the biggest compliance risks in telehealth GLP-1 prescribing?
1) Prescribing without adequate evaluation (must obtain history, assess BMI/comorbidities, rule out contraindications—even via video)
2) Using unlicensed compounding pharmacies (FDA has warned about questionable semaglutide sources; vet your pharmacy partners)
3) Practicing in states where you’re not licensed
4) For NPs, prescribing without required physician supervision in restricted-practice states
5) Poor documentation of informed consent, especially for off-label use (e.g., using Ozempic for obesity when Wegovy is the approved brand)
Mitigate by: maintaining thorough telehealth documentation, using FDA-approved meds or vetted compounders, ensuring proper state licensure, and having clear informed consent processes.
How many GLP-1 patients can I realistically manage without burning out?
Depends on your support structure. A solo psychiatrist doing everything (evaluations, follow-ups, lifestyle counseling, portal messages) might cap at 30-50 active GLP-1 patients before feeling overwhelmed. With team support (RN handling routine messages, health coach doing group sessions, standardized workflows), you could manage 100-150+ active patients comfortably. Start small (10-20 patients) and scale gradually, adding support staff as revenue justifies it. Monitor your stress level—if you’re dreading GLP-1 appointments, you’ve grown too fast.
Axios – ‘Just how many Americans are taking GLP-1s now’ (May 27, 2025) – www.axios.com
ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry’ (Oct 20, 2025) – www.confectionerynews.com
Time – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny’ (Aug 22, 2025) – time.com
Axios – ‘America’s doctors need more obesity medicine training’ (May 28, 2024) – www.axios.com
Axios – ‘States slow to cover GLP-1s for weight loss’ (Nov 5, 2024) – www.axios.com
Find the right provider for your needs — select your state to find expert care near you.